PGI17 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL

May 1, 2010, 00:00
10.1016/S1098-3015(10)72336-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)72336-6/fulltext
Title : PGI17 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72336-6&doi=10.1016/S1098-3015(10)72336-6
First page :
Section Title :
Open access? : No
Section Order : 934
Categories :
Tags :
Regions :
ViH Article Tags :